
Translating Discovery into Health
University of California Biomedical Research Acceleration, Integration, & Development (UC BRAID) creates opportunities to improve health for Californians and beyond. Our platform for collaboration helps catalyze innovative ideas and build and leverage shared resources. READ MORE
PROMOTING EFFICIENCIES
So long, silos! UC BRAID and our network of research administration experts across the University of California work to test and implement new ways of working together more efficiently. We break down barriers, making communication more effective, reducing impediments and redundancies, ultimately making it faster and easier for UC to conduct the next generation of research.

Contracting
Contracting offices face increasing internal and external pressure to improve turnaround times for clinical trial contract execution. To address these challenges, UC BRAID convened a network of campus contracting leadership. More...

Participant Recruitment
Participant recruitment is a significant challenge in many studies involving human subjects. The 5 campuses of UC BRAID, UC Riverside, and Stanford have partnered to build a portfolio of tools and services to improve the participant recruitment processes. More...
IRB

UC BRAID works closely with campus IRB Directors and staff as they adapt to a changing regulatory landscape. This close collaboration provides opportunities for us to test new approaches that streamline IRB approval and speed up clinical trial activation. More...


UC BRAID facilitated linking our clinical trial networks, for the first time giving our patients access to cutting edge therapies across the UC health systems through single IRB review and a simplified contracting process.
Gary Firestein, Director
Clinical and Translational Research Institute ,
UC San Diego

DEVELOPING TOOLS
We are excited to showcase a diverse set of tools developed by our partners across the University of California. One example is a clinical trial finder that helps researchers, patients and physicians explore the broad portfolio of trials across the state. Another is a toolkit to assist UC investigators through the contracting process for investigator-initiated trials. Take a look and see what else is on offer.
UC ReX
Legacy tool for research study cohorts from 15m de-identified patient records across UC Health
NEWS AND EVENTS

Advancing the Next Generation of Health Research
Together a diverse set of leaders, faculty, administrators, and partners learned about exciting advances, influenced UC BRAID’s objectives, and discussed new ways to position BRAID to be ready -- now and into the future.
Date: October 3, 2018 Los Angeles
NEWS AND EVENTS

UC BRAID Funding for COVID-19 Health Equity Projects
In September 2020, UC Biomedical Research Acceleration, Innovation and Development (UC BRAID) launched the Addressing Health Equity in COVID Research initiative which provided $100K in support to each of the 5 UC Clinical and Translational Science Award (CTSA) campuses to enhance existing research projects and enable increased inclusion. The initiative was a mechanism to immediately provide support to existing project (e.g. clinical trials, social/behavioral, and community engagement research) and address the intersecting challenges of COVID-19 and health disparity.
Date: November 5, 2021 | California

UC BRAID funds Davis CTSC program addressing food insecurity in Sacramento communities hard-hit by COVID-19
Recently, the UC Davis Clinical and Translational Science Center (CTSC) designed and funded Food for All, a grocery distribution program focused on addressing COVID-19-aggravated food insecurity among Asian communities in South Sacramento.
Date: May 21, 2021 | Sacramento

Transfer of UC COVID-19 Patient Information to Federal Database
“We were very involved in the pandemic from Day One,” said Dan Cooper, chair of UC BRAID, a coalition of all five UC medical centers with NIH funding for translational research. Researchers pursuing COVID-19-related studies can apply for quick access to detailed case data, including demographics, symptoms, medications, lab test results and outcomes.
Date: March 24, 2021 | Irvine